Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 387

1.

Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy.

Ohyama C, Hosono M, Nitta K, Oh-eda M, Yoshikawa K, Habuchi T, Arai Y, Fukuda M.

Glycobiology. 2004 Aug;14(8):671-9. Epub 2004 Mar 24.

PMID:
15044396
[PubMed - indexed for MEDLINE]
Free Article
2.

alpha1,2-Fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer.

Fukushima K, Satoh T, Baba S, Yamashita K.

Glycobiology. 2010 Jan;20(4):452-60. doi: 10.1093/glycob/cwp197. Epub 2009 Dec 11.

PMID:
20008118
[PubMed - indexed for MEDLINE]
Free Article
3.
4.

Glycosylation of urinary prostate-specific antigen in benign hyperplasia and cancer: assessment by lectin-binding patterns.

Janković MM, Kosanović MM.

Clin Biochem. 2005 Jan;38(1):58-65.

PMID:
15607318
[PubMed - indexed for MEDLINE]
5.

Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.

Peracaula R, Tabarés G, Royle L, Harvey DJ, Dwek RA, Rudd PM, de Llorens R.

Glycobiology. 2003 Jun;13(6):457-70. Epub 2003 Jan 3.

PMID:
12626390
[PubMed - indexed for MEDLINE]
Free Article
6.

Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer.

Batabyal SK, Majhi R, Basu PS.

Neoplasma. 2009;56(1):68-71.

PMID:
19152248
[PubMed - indexed for MEDLINE]
7.

Lectin and serum-PSA interaction as a screening test for prostate cancer.

Basu PS, Majhi R, Batabyal SK.

Clin Biochem. 2003 Jul;36(5):373-6.

PMID:
12849869
[PubMed - indexed for MEDLINE]
8.

Strategy for sensitive and specific detection of molecular forms of PSA based on 2DE and kinetic analysis: a step towards diagnosis of prostate cancer.

Kumar V, Hassan MI, Singh AK, Dey S, Singh TP, Yadav S.

Clin Chim Acta. 2009 May;403(1-2):17-22. doi: 10.1016/j.cca.2008.11.020. Epub 2008 Dec 3.

PMID:
19118539
[PubMed - indexed for MEDLINE]
9.

Serial lectin affinity chromatography demonstrates altered asparagine-linked sugar-chain structures of prostate-specific antigen in human prostate carcinoma.

Sumi S, Arai K, Kitahara S, Yoshida K.

J Chromatogr B Biomed Sci Appl. 1999 Apr 30;727(1-2):9-14.

PMID:
10360417
[PubMed - indexed for MEDLINE]
10.

Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.

Tabarés G, Radcliffe CM, Barrabés S, Ramírez M, Aleixandre RN, Hoesel W, Dwek RA, Rudd PM, Peracaula R, de Llorens R.

Glycobiology. 2006 Feb;16(2):132-45. Epub 2005 Sep 21.

PMID:
16177264
[PubMed - indexed for MEDLINE]
Free Article
11.

Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard.

Bélanger A, van Halbeek H, Graves HC, Grandbois K, Stamey TA, Huang L, Poppe I, Labrie F.

Prostate. 1995 Oct;27(4):187-97.

PMID:
7479385
[PubMed - indexed for MEDLINE]
12.

[Tumor markers in prostate cancer--clinical significance and future prospect of prostate specific antigen (PSA)].

Tsuchiya N, Ohyama C, Habuchi T.

Gan To Kagaku Ryoho. 2005 Feb;32(2):275-80. Japanese.

PMID:
15751649
[PubMed - indexed for MEDLINE]
13.

Sialylation and fucosylation of cancer-associated prostate specific antigen.

Kosanović MM, Janković MM.

J BUON. 2005 Apr-Jun;10(2):247-50.

PMID:
17343337
[PubMed]
14.

Prostate specific antigen in benign prostatic hyperplasia: purification and characterization.

Chen Z, Chen H, Stamey TA.

J Urol. 1997 Jun;157(6):2166-70.

PMID:
9146608
[PubMed - indexed for MEDLINE]
15.

Separation of enzymatically active and inactive prostate-specific antigen (PSA) by peptide affinity chromatography.

Wu P, Stenman UH, Pakkala M, Närvänen A, Leinonen J.

Prostate. 2004 Mar 1;58(4):345-53.

PMID:
14968435
[PubMed - indexed for MEDLINE]
16.

Characterization and determination of the complex between prostate-specific antigen and alpha 1-protease inhibitor in benign and malignant prostatic diseases.

Zhang WM, Finne P, Leinonen J, Stenman UH.

Scand J Clin Lab Invest Suppl. 2000;233:51-8.

PMID:
11317942
[PubMed - indexed for MEDLINE]
17.

Binding of serum prostate antigen to concanavalin A in patients with cancer or hyperplasia of the prostate.

Barak M, Mecz Y, Lurie A, Gruener N.

Oncology. 1989;46(6):375-7.

PMID:
2479896
[PubMed - indexed for MEDLINE]
18.

Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer.

Gross M, Top I, Laux I, Katz J, Curran J, Tindell C, Agus D.

Clin Cancer Res. 2007 Apr 1;13(7):1979-86.

PMID:
17404077
[PubMed - indexed for MEDLINE]
Free Article
19.

Characterization of the carbohydrate binding specificity of the leukoagglutinating lectin from Maackia amurensis. Comparison with other sialic acid-specific lectins.

Knibbs RN, Goldstein IJ, Ratcliffe RM, Shibuya N.

J Biol Chem. 1991 Jan 5;266(1):83-8.

PMID:
1985926
[PubMed - indexed for MEDLINE]
Free Article
20.

Crystal structure of human prostate-specific antigen in a sandwich antibody complex.

Stura EA, Muller BH, Bossus M, Michel S, Jolivet-Reynaud C, Ducancel F.

J Mol Biol. 2011 Dec 9;414(4):530-44. doi: 10.1016/j.jmb.2011.10.007. Epub 2011 Oct 20.

PMID:
22037582
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk